NCT07493421 2026-03-25
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Unidade Local de Saúde São João
Phase NA Recruiting
Clinical Trials
8 trialsNCT03422432 2025-02-03
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
National Cancer Centre, Singapore
Phase NA Completed
NCT02969122 2024-09-19
Cy-plus
Peking University
Phase NA Terminated
NCT02179489 2022-06-27
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Zhejiang University
Phase NA Completed
NCT05228743 2022-02-08
Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT04889768 2021-05-17
HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03349827 2020-03-24
HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer
Wuhan University
Phase NA Terminated
NCT03398512 2020-03-24
HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer
Wuhan University
Phase NA Terminated